First Time Loading...
G

Gemini Therapeutics Inc
NASDAQ:GMTX

Watchlist Manager
Gemini Therapeutics Inc
NASDAQ:GMTX
Watchlist
Price: 19.89 USD 47.33% Market Closed
Updated: Jun 9, 2024

Gemini Therapeutics Inc
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gemini Therapeutics Inc
Common Shares Outstanding Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
G
Gemini Therapeutics Inc
NASDAQ:GMTX
Common Shares Outstanding
$17.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Common Shares Outstanding
$1.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Common Shares Outstanding
$1.2B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Common Shares Outstanding
$536.4m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Common Shares Outstanding
$258.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Common Shares Outstanding
$110.2m
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
1%

See Also

What is Gemini Therapeutics Inc's Common Shares Outstanding?
Common Shares Outstanding
17.4m USD

Based on the financial report for Dec 31, 2022, Gemini Therapeutics Inc's Common Shares Outstanding amounts to 17.4m USD.

What is Gemini Therapeutics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 1Y
303%

Over the last year, the Common Shares Outstanding growth was 303%.